Zebra Technologies has played a role in coronavirus testing to fight the pandemic, and now the barcode company has a new role to play in preventing the further spread of the deadly virus, CEO Anders Gustaffson told CNBC’s Jim Cramer on Friday.
While Zebra’s products have been used to track samples from mass tracking agencies, the company is also used to distribute vaccines in what is known as the cold chain, a temperature-controlled supply chain.
“Our vaccine bottle labels”, which can also be used on boxes and pallets, “change color depending on the temperature,” said Gustaffson in a “Bad money“Interview.
The labels are from Temptime, a manufacturer of temperature monitoring solutions for the healthcare sector that the Lincolnshire, Illinois-based company acquired nearly two years ago.
Pfizer and BioNTech was the first company in the running on Friday to make a viable Covid-19 vaccine for which an application was filed Emergency approval from the U.S. Food and Drug Administration. The verification process is expected to take a few weeks. Thereafter, 100 million cans are to be made available to the US government as part of Operation Warp Speed.
Pfizer plans to ship its vaccine, which will require ultra-cold storage, once approved.
This is where zebra comes in. While Gustaffson didn’t say which vaccine manufacturers his company works with, he said Zebra will play a role in transporting the vaccinations.
“We can help with quality control of the vaccine to make sure it is in the correct temperature range when injected into someone and administered to ensure maximum efficiency,” he explained.
Pfizer said its vaccine was 95% effective in preventing the contraction of Covid-19, the sometimes fatal disease caused by a novel coronavirus. Moderna is another drug company in late-stage studies for a vaccine candidate that the company says is 94% effective.
Vaccines must be transported in cold conditions, otherwise they can become ineffective.
“We also now have our new Reflexis software applications in which we have a module that pharmacies and other smaller clinics can use to schedule all patients to come in and be injected,” said Gustaffson.
Zebra stock was down 1% on Friday, closing at $ 354.99 per share. The stock is up nearly 39% since the start of the year.